Oxford Centre for Diabetes, Endocrinology and Metabolism
OCDEM is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, we aim to enhance understanding of these diseases and to accelerate the search for new treatments and cures.
Head of OCDEM
About OCDEM
The Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) is a pioneering centre that combines clinical care, research and education in diabetes, endocrine and metabolic diseases.
Read more
© Martin Phelps
Diabetes Trials Unit
The Diabetes Trials Unit (DTU) is a fully registered UKCRC Clinical Trials Unit, specialising in performing national and multinational clinical trials related to diabetes.
Read moreGene that contributes to female body shape may increase risk of type 2 diabetes
Scientists at the University of Oxford have identified a gene that in women is linked to the creation and location of new fat cells and in turn contributes to an increased risk of type 2 diabetes.
Read moreSeminars and Events
Our Wednesday seminars are supported by an unrestricted educational grant from Boehringer-Ingelheim
Latest Publications
-
δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin.
Briant LJB. et al, (2018), J Physiol, 596, 197 - 215
-
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).
Mentz RJ. et al, (2017), Am Heart J, 187, 1 - 9
-
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Holman RR. et al, (2017), Lancet Diabetes Endocrinol, 5, 877 - 886
-
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
Howles SA. et al, (2017), JCI Insight, 2
OCDEM Vacancies